Published in Schizophr Res on January 31, 2006
Cognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients. Psychol Med (2012) 2.07
What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr Bull (2008) 1.80
The myth of schizophrenia as a progressive brain disease. Schizophr Bull (2012) 1.21
Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Rev Neurother (2010) 1.10
Brain derived neurotropic factor in first-episode psychosis. Schizophr Res (2007) 1.07
Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia. Br J Psychiatry (2008) 1.05
Normalization of cortical gray matter deficits in nonpsychotic siblings of patients with childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry (2011) 1.05
Methamphetamine users show greater than normal age-related cortical gray matter loss. Addiction (2011) 0.99
Focal and global brain measurements in siblings of patients with schizophrenia. Schizophr Bull (2011) 0.92
Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosis. Biol Psychiatry (2010) 0.92
Duration of untreated psychosis is associated with temporal and occipitotemporal gray matter volume decrease in treatment naïve schizophrenia. PLoS One (2013) 0.89
Untreated illness duration correlates with gray matter loss in first-episode psychoses. Neuroreport (2009) 0.88
The role of untreated psychosis in neurodegeneration: a review of hypothesized mechanisms of neurotoxicity in first-episode psychosis. Can J Psychiatry (2014) 0.86
Treatment implications of the schizophrenia prodrome. Curr Top Behav Neurosci (2010) 0.82
Gray matter changes in subjects at high risk for developing psychosis and first-episode schizophrenia: a voxel-based structural MRI study. Front Psychiatry (2013) 0.80
The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions. Schizophr Res (2010) 0.76
Duration of Untreated Psychosis and Brain Function during Verbal Fluency Testing in First-Episode Schizophrenia: A Near-Infrared Spectroscopy Study. Sci Rep (2015) 0.76
Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People's Republic of China. Neuropsychiatr Dis Treat (2014) 0.75
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs. J Neurosci (2006) 12.34
TREM2 variants in Alzheimer's disease. N Engl J Med (2012) 11.35
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry (2006) 9.44
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Neurophysiological architecture of functional magnetic resonance images of human brain. Cereb Cortex (2005) 7.87
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry (2004) 5.95
Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet (2003) 4.91
Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry (2003) 4.84
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet (2003) 4.84
Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet (2012) 4.05
Ethnic density as a buffer for psychotic experiences: findings from a national survey (EMPIRIC). Br J Psychiatry (2012) 4.05
Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry (2002) 4.03
A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry (2002) 3.95
Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry (2004) 3.85
Why psychiatry can't afford to be neurophobic. Br J Psychiatry (2009) 3.80
Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry (2009) 3.67
Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry (2002) 3.59
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35
Undirected graphs of frequency-dependent functional connectivity in whole brain networks. Philos Trans R Soc Lond B Biol Sci (2005) 3.11
Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry (2010) 3.05
Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet (2011) 2.99
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79
Symmetries in human brain language pathways correlate with verbal recall. Proc Natl Acad Sci U S A (2007) 2.78
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ (2012) 2.70
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57
Outcomes of conduct problems in adolescence: 40 year follow-up of national cohort. BMJ (2009) 2.47
Prevalence and correlates of self-reported psychotic symptoms in the British population. Br J Psychiatry (2004) 2.44
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs. Br J Psychiatry (2012) 2.41
High-potency cannabis and the risk of psychosis. Br J Psychiatry (2009) 2.41
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry (2011) 2.37
Disease-relevant autoantibodies in first episode schizophrenia. J Neurol (2010) 2.33
Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One (2012) 2.33
Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res (2004) 2.30
Barriers and facilitators of disclosures of domestic violence by mental health service users: qualitative study. Br J Psychiatry (2010) 2.27
Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain (2002) 2.26
The hallucinating brain: a review of structural and functional neuroimaging studies of hallucinations. Neurosci Biobehav Rev (2007) 2.25
Gonadotropin-releasing hormone receptors. Endocr Rev (2004) 2.22
Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science (2008) 2.20
Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction (2007) 2.20
Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17
Diffusion tensor imaging in schizophrenia. Biol Psychiatry (2005) 2.14
Fractional Gaussian noise, functional MRI and Alzheimer's disease. Neuroimage (2005) 2.13
Schizophrenia in the offspring of antenatally depressed mothers in the northern Finland 1966 birth cohort: relationship to family history of psychosis. Am J Psychiatry (2009) 2.11
A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res (2011) 2.09
Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation. J Neurosci (2009) 2.07
Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study. Br J Psychiatry (2011) 2.06
Phenomenology, science and the anthropology of the self: a new model for the aetiology of psychosis. Br J Psychiatry (2004) 2.03
A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disord (2011) 2.03
Replication of CLU, CR1, and PICALM associations with alzheimer disease. Arch Neurol (2010) 2.02
Adolescents who were born very preterm have decreased brain volumes. Brain (2002) 1.97
Mapping the brain in autism. A voxel-based MRI study of volumetric differences and intercorrelations in autism. Brain (2004) 1.97
Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study. Arch Gen Psychiatry (2008) 1.96
What sleep characteristics predict cognitive decline in the elderly? Sleep Med (2012) 1.96
Temporal course of auditory hallucinations. Br J Psychiatry (2004) 1.95
Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr Bull (2009) 1.94
White matter integrity and cognitive impairment in first-episode psychosis. Am J Psychiatry (2010) 1.92
Neural responses to happy facial expressions in major depression following antidepressant treatment. Am J Psychiatry (2007) 1.92
Grey and white matter distribution in very preterm adolescents mediates neurodevelopmental outcome. Brain (2007) 1.91
Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry (2007) 1.91
Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry (2008) 1.89
Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry (2004) 1.87
Wavelets and functional magnetic resonance imaging of the human brain. Neuroimage (2004) 1.84
Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study. Br J Psychiatry (2005) 1.83
Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry (2006) 1.81
Insomnia and health-related quality of life. Sleep Med Rev (2009) 1.79
Tract-specific anisotropy measurements in diffusion tensor imaging. Psychiatry Res (2005) 1.79